Areas eligible for SMC and areas where SMC is implemented in 2021

Guinea-Bissau 2021 SMC season |
# of children targeted |
# of children reached |
Coverage |
Cycle 1 |
116,583 |
112,732 |
97% |
Cycle 2 |
116,583 |
110,790 |
95% |
Cycle 3 |
116,583 |
108,237 |
93% |
Cycle 4 |
116583 |
101815 |
87% |
Children receiving at least 4 cycles |
116583 |
101815 |
87% |
Surveillance de la couverture, la conformité et l'efficacité pendant la campagne du CPS 2020

Monitoring from coverage
- Coverage is monitored from the third full dose
Monitoring for compliance
- Direct supervision of distribution teams
- External evaluation
Evaluating effectiveness
- Effectiveness is evaluated by monitoring for the decrease in malaria cases in children 3-59 months during the SMC period
Successes, opportunities, challenges and proposed solutions in 2021
Successes
- Adoption of the door-to-door strategy and observed doses;
- Timely planning and adapted to the Covid-19 context;
- Engagement of religious, traditional and community leaders, ASC, RAS and DRS/ERS;
- Introduction of “tablets” in health areas to collect individual data in eligible regions.
Action steps
- Carry out a study on the impact assessment of SMC in the regions of Bafatá and Gabú;
- Implement Real Time Monitoring (RTM) during the SMC campaign;
- Extend SMC to other health regions with eligibility criteria.
Challenges
- Reinforcement of interpersonal and mass communication;
- Strengthening advocacy with traditional and religious administrative authorities;
- Intensification of the application of drug surveillance;
- Good coordination at all levels; Extend SMC strategies to other eligible regions;
- Correct management of adverse reaction cases by ASCs;
Proposed solutions
- Issue awareness messages through media and ASC before and during the SMC campaign;
- Intensify meetings with community, religious, and administrative leaders;
- Equip health structures with medicines to deal with cases of adverse reactions.
- Briefing the campaign situation at all levels;
- Advocate with technical and financial partners;
- Train ASC on how to properly manage adverse reaction cases.
Research priorities for 2021
- Carry out a study on the impact assessment of SMC in the regions of Bafatá and Gabú in December 2022.
Partners
- Bandim Health Project (PSB) and OPT-SMC project